Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Merck and MacroGenics collaborate on immuno-oncology

Evaluates margetuximab with Keytruda for gastric cancer

- PMLiVE

Is Pfizer eyeing a merger with Allergan?

Combined company value could be $330bn

- PMLiVE

Jane Osbourn to chair BIA board

VP of R&D atMedimmune to chair BioIndustry Association board

- PMLiVE

dna boosts London offering

Healthcarecomms agency launches specialist PR unit

- PMLiVE

Clark Health Communications in Farringdon move

Expands into new London offices

- PMLiVE

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart

Bristol-Myers Squibb (BMS) building

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

Supports analysts prediction BMS' Opdivo will become market leader

- PMLiVE

Amgen gets FDA nod for virus-based melanoma therapy

Advisory committee votes in favour of drug after three month delay

- PMLiVE

Ardelyx appoints William Bertrand Jr to board of directors

Executive VP of Infinity Pharmaceuticals joins the team

- PMLiVE

Consultation begins on new patient access scheme

EMA hopes PRIME will improve development of prioritymedicines and ease access concerns

- PMLiVE

Vertex forges ties with gene editing firm CRISPR Therapeutics

Aims to find new treatments for genetic diseases such as cystic fibrosis

- PMLiVE

Amgen’s Imlygic recommended for European approval

First-in-class oncolytic immunotherapy wins CHMP positive opinion

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links